HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Clinical trials for HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE) explained in plain language.
Never miss a new study
Get alerted when new HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE) trials appear
Sign up with your email to follow new studies for HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nasal gene therapy offers new hope for brain injury patients
Disease control ENROLLING_BY_INVITATIONThis study follows 25 people aged 2 to 65 with cerebral palsy or brain damage from lack of oxygen who have already received a new gene therapy given as a nose spray. The therapy delivers 15 genes meant to repair the brain, reduce inflammation, and improve movement and thinking. R…
Matched conditions: HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could melatonin help save Babies' brains after birth injury?
Disease control OngoingThis study tests whether giving melatonin to full-term newborns with hypoxic-ischemic encephalopathy (HIE) — a type of brain injury from lack of oxygen at birth — can improve survival and reduce brain damage. Half of the 110 babies will receive a single dose of melatonin through …
Matched conditions: HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Phase: PHASE2 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC